Patents by Inventor Donald Kellerman

Donald Kellerman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11839683
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Grant
    Filed: May 25, 2021
    Date of Patent: December 12, 2023
    Assignee: Emergex USA Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Publication number: 20230255881
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: April 21, 2023
    Publication date: August 17, 2023
    Inventors: Mahmoud Ameri, Donald Kellerman, Yi Ao
  • Patent number: 11660264
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: May 30, 2023
    Assignee: Emergex USA Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Yi Ao
  • Patent number: 11660265
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods for treating migraine by administering zolmitriptan using an adhesive dermally-applied microarray (ADAM) resulting in rapid and durable pain relief, pain freedom and reduction in most bothersome migraine-associated symptoms (MBS), or a combination thereof.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: May 30, 2023
    Assignee: Emergex USA Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao, Peter C. Schmidt
  • Publication number: 20210275445
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: May 25, 2021
    Publication date: September 9, 2021
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Patent number: 11058630
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: July 13, 2021
    Assignee: Zosano Pharma Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Publication number: 20200000712
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described.
    Type: Application
    Filed: June 27, 2019
    Publication date: January 2, 2020
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao, Peter C. Schmidt
  • Publication number: 20190070103
    Abstract: Applicant hereby submits a substitute abstract that is double spaced.
    Type: Application
    Filed: August 23, 2018
    Publication date: March 7, 2019
    Inventors: Mahmoud Ameri, Donald Kellerman, Yi Ao
  • Publication number: 20180153799
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: January 29, 2018
    Publication date: June 7, 2018
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Patent number: 9918932
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: March 20, 2018
    Assignee: Zosano Pharma Corporation
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao
  • Publication number: 20170239174
    Abstract: Compositions, devices and methods employing therapeutic concentrations of a triptan for treatment of migraine are described. Also described are methods and apparatuses for delivery of zolmitriptan for achieving a Tmax as quick as 2 minutes and not later than 30 minutes in the majority of subjects.
    Type: Application
    Filed: February 21, 2017
    Publication date: August 24, 2017
    Inventors: Mahmoud Ameri, Donald Kellerman, Peter E. Daddona, Yi Ao